The US Treasury reported a nearly $2 trillion budget deficit for the 2026 fiscal year, a 12% increase from the previous year and the third-highest on record. This marks the 25th consecutive year the US has run a deficit, with spending driven by Social Security, Medicare, and rising interest costs. Despite increased tax revenues, the national debt surpassed $40 trillion, raising concerns about long-term financial health. The government continues to rely on growth and tariff strategies to manage the debt burden.
The U.S. budget deficit for fiscal 2026 is reported at nearly $2 trillion, a 12% increase from the previous year, as of Oct 16, 2026 23:41 WIB. For readers following U.S. stocks, here is Pluang's market snapshot: out of 150 priced US stocks, 62 rose and 86 fell today. Notable movers include Snowflake Inc (SNOW) at USD 309.76 with a 1-day change of -7.55% and Pluang order activity showing 84% Sell / 16% Buy, Palantir Technologies Inc (PLTR) at USD 187.28 down 6.59% with 82% Sell / 18% Buy, and BlackBerry Limited (BB) at USD 8.21 down 5.63% with 0% Sell / 100% Buy. The most notable figure is the 84% sell activity on SNOW.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
